LINC01559 and colorectal carcinoma: One study discovered that LINC01559 was downregulated in CRC tissues compared to normal tissues, and lower expression of LINC01559 in CRC patients indicated a poor prognosis; this study also revealed a novel mechanism of METTL3-mediated m6A modification on LINC01559 as the mechanism of CRC progression [14].